Impact of epidermal growth factor receptor (EGFR) activating mutations and their targeted treatment in the prognosis of stage IV non-small cell lung cancer (NSCLC) patients harboring liver metastasis

  1. Castañón, E.
  2. Rolfo, C.
  3. Viñal, D.
  4. López, I.
  5. Fusco, J.P.
  6. Santisteban, M.
  7. Martin, P.
  8. Zubiri, L.
  9. Echeveste, J.I.
  10. Gil-Bazo, I.
Aldizkaria:
Journal of Translational Medicine

ISSN: 1479-5876

Argitalpen urtea: 2015

Alea: 13

Zenbakia: 1

Mota: Artikulua

DOI: 10.1186/S12967-015-0622-X GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus